BEAM vs MDLZ · rev $32.2M vs P/E 30, rev $38.54B
Beam Therapeutics Inc (BEAM) versus Mondelez International Inc (MDLZ) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
Latest reported BEAM revenue for 2026-06-30 was $32.2M. Net income was -$217.0M. Revenue was up 1.5% from 2026-03-31 to 2026-06-30. BEAM currently screens at market cap $2.01B.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
BEAM currently screens at market cap $2.01B. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
Not investment advice. Open the BEAM and MDLZ stock pages for the full models.
Not investment advice.